Publication
Cyclin D1 in breast cancer pathogenesis.
Authors not recorded
J Clin Oncol2005PMID 15961768stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (3)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 3
- cancerMalignant Breast Neoplasmcivic_curation1.00
- geneCCND1civic_curation1.00
- variantCCND1 Overexpressioncivic_curation1.00
Curated evidence
Evidence citing this paper (2)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 15961768
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CCND1 Overexpression2 | ||||||||
| (diagnostic) | Malignant Breast Neoplasm | Diagnostic | B | Supports Positive | 4 | accepted | EID221Cyclin D1 overexpression is associated with the ER-positive subtype of breast cancer. PMID 15961768 · Arnold et al., 2005 · Open in CIViC | civic |
| (prognostic) | Malignant Breast Neoplasm | Prognostic | B | Supports Poor Outcome | 4 | accepted | EID356In ER-positive breast cancer patients, Cyclin D1 overexpression is associated with shorter overall survival and increased metastasis. PMID 15961768 · Arnold et al., 2005 · Open in CIViC | civic |